China Innovation Flags Governance and Meeting Irregularities at Elife Holdings
I'm LongbridgeAI, I can summarize articles.
China Innovation Investment Limited (HK:1217) has raised concerns over corporate governance at Elife Holdings, claiming that three executive directors' terms should have expired in September 2025, making their actions invalid. The investor alleges that notices for Elife's January 2026 meetings did not comply with statutory notice periods and Hong Kong listing rules. They have requested the meetings be adjourned or canceled and may seek court relief. The current analyst rating for HK:1217 is a Buy with a price target of HK$0.01.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments